Weickert, Martin O., Robbins, Tim, Kyrou, Ioannis, Hopper, Adam, Pearson, Eilish, Barber, Thomas M., Kaltsas, Gregory and Randeva, Harpal S. (2021) Impact of the COVID-19 pandemic on neuroendocrine tumour services in England. Endocrine, 71 . pp. 14-19. doi:10.1007/s12020-020-02564-2

Preview	PDF WRAP-impact-COVID-19-pandemic-neuroendocrine-tumour-services-England-Barber-2020.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (387Kb) | Preview
	PDF WRAP-impact-COVID-19-pandemic-neuroendocrine-tumour-services-England-Barber-2020.pdf - Accepted Version Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Download (1278Kb)

Request Changes to record.

Abstract

Purpose
During the COVID-19 pandemic, there have been particular concerns regarding the related impact on specialist tumour services. Neuroendocrine tumour (NET) services are delivered in a highly specialised setting, typically delivered in a small number of centres that fulfil specific criteria as defined by the European Neuroendocrine Tumour Society (ENETS). We aimed to address the COVID-19-related impact on specialist NET tumour services in England and other countries.

Methods
Electronic survey addressing patient access and delivery of care distributed to all ENETS Centres of Excellence (CoE) in England and matching number of ENETS CoE elsewhere. Semi-quantitative and qualitative analyses of survey responses were performed.

Results
Survey response of ENETS CoE in England was 55% (6/11). Responses from six non-UK ENETS CoE elsewhere were received and analysed in a similar manner. Relevant disruption of various NET services was noted across all responding Centres, which included delayed patient appointments and investigations, reduced availability of treatment modalities including delayed surgical treatment and a major negative impact on research activities. The comparison between English and non-UK ENETS CoE suggested that the former had significantly greater concerns related to future research funding (p = 0.014), whilst having less disruption to multidisciplinary meetings (p = 0.01). A trend was also noted towards virtual patient appointments in ENETS CoE in England vs. elsewhere (p = 0.092).

Conclusions
Restoration of highly specialised NET services following COVID-19 and planning for future service delivery and research funding must take account of the severe challenges encountered during the pandemic.

Item Type:	Journal Article
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions:	Faculty of Medicine > Warwick Medical School > Biomedical Sciences Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Medicine > Warwick Medical School Faculty of Science > WMG (Formerly the Warwick Manufacturing Group)
Library of Congress Subject Headings (LCSH):	COVID-19 (Disease), Neuroendocrine tumors
Journal or Publication Title:	Endocrine
Publisher:	Springer
ISSN:	1355-008X
Official Date:	5 January 2021
Dates:	Date Event 5 January 2021 Available 22 November 2020 Accepted
Date of first compliant deposit:	23 November 2020
Volume:	71
Page Range:	pp. 14-19
DOI:	10.1007/s12020-020-02564-2
Status:	Peer Reviewed
Publication Status:	Published
Publisher Statement:	This is a post-peer-review, pre-copyedit version of an article published in Endocrine. The final authenticated version is available online at: http://dx.doi.org/[insert DOI].
Access rights to Published version:	Open Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item